Sopharma issued the following announcement on July 5.

Sopharma AD notifies that for June 2019 the Company recorded an increase in sales of 1% compared to the same month of 2018, incl. 6% decrease in sales for the domestic market and 7% growth in export sales.

In the first six months of 2019 the revenues from sales of production increased by 1% compared to the same period of 2018, incl. 11% decrease in domestic sales and 10% increase of export sales.

Original source can be found here.